• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.67% Nasdaq Up 1.47%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    22.47 Down 0.28(1.23%) 4:00PM EDT
    |After Hours : 22.40 Down 0.07 (0.31%) 6:13PM EDT
    Add to Portfolio
    Prev Close:22.75
    Open:22.72
    Bid:21.25 x 1000
    Ask:22.88 x 100
    1y Target Est:23.17
    Beta:0.31
    Next Earnings Date:N/A
    Day's Range:22.15 - 22.81
    52wk Range:2.50 - 24.48
    Volume:864,333
    Avg Vol (3m):1,536,970
    Market Cap:671.63M
    P/E (ttm):N/A
    EPS (ttm):-0.97
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSDown 1.23%671.63M
    BVTI 0.00%N/A
    DNDN 0.00%N/A
    VICLUp 0.26%84.18M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):618.98
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-15) :-1.12
    Quarterly EPS Est (Apr-15) :-0.28
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback